269 related articles for article (PubMed ID: 20462963)
21. Histopathological atlas of renal diseases: light chain deposition disease.
Ferrario F; Rastaldi MP
J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal Gammopathy of Renal Significance.
Leung N; Bridoux F; Nasr SH
N Engl J Med; 2021 May; 384(20):1931-1941. PubMed ID: 34010532
[No Abstract] [Full Text] [Related]
24. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
25. Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis.
Roccatello D; Fenoglio R; Baldovino S; Naretto C; Ferro M; Barreca A; Rossi D; Sciascia S
Autoimmun Rev; 2020 Sep; 19(9):102622. PubMed ID: 32663622
[TBL] [Abstract][Full Text] [Related]
26. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.
Herrera GA; Joseph L; Gu X; Hough A; Barlogie B
Arch Pathol Lab Med; 2004 Aug; 128(8):875-9. PubMed ID: 15270616
[TBL] [Abstract][Full Text] [Related]
27. Why renal biopsy is crucial in monoclonal gammopathy of renal significance (MGRS).
Ciocchini M; Musso CG
Int Urol Nephrol; 2019 May; 51(5):899-900. PubMed ID: 30888599
[No Abstract] [Full Text] [Related]
28. Glomerular, Mesangial, and Tubular Cytoplasmic Fibrillary Inclusions in a Patient with Light-Chain Proximal Tubulopathy.
Chung EYM; McIlroy K; Fung C; Seshan SV; Moran S; Coleman PL
Nephron; 2020; 144(4):190-194. PubMed ID: 32018256
[TBL] [Abstract][Full Text] [Related]
29. The radical treatment of paraprotein disorders affecting the kidney.
Peniket AJ; Littlewood TJ; Winearls CG
Nephrol Dial Transplant; 2003 Aug; 18(8):1431-4. PubMed ID: 12897075
[No Abstract] [Full Text] [Related]
30. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
[TBL] [Abstract][Full Text] [Related]
31. [Paraprotein-related kidney disease. Experience in 22 cases].
Jerez J; Juanet C; Sharp J; Ernst D; Méndez GP; Sepúlveda RA
Rev Med Chil; 2020 Aug; 148(8):1059-1067. PubMed ID: 33399771
[TBL] [Abstract][Full Text] [Related]
32. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
Sethi S; Rajkumar SV; D'Agati VD
J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
[TBL] [Abstract][Full Text] [Related]
33. Kidney disease and multiple myeloma.
Heher EC; Rennke HG; Laubach JP; Richardson PG
Clin J Am Soc Nephrol; 2013 Nov; 8(11):2007-17. PubMed ID: 23868898
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics of light chain proximal tubulopathy with light chain inclusions involving multiple renal cell types
.
Li X; Xu F; Liang D; Liang S; Zhu X; Zhang M; Huang X; Liu Z; Zeng C
Clin Nephrol; 2018 Feb; 89(2):83-92. PubMed ID: 29035194
[TBL] [Abstract][Full Text] [Related]
35. [Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma].
Gorchakova SV; Rekhtina IG; Iatskov KV; Sukhanova GA; Golitsina EP; Varshavskiĭ VA; Biriukova LS
Ter Arkh; 2009; 81(7):78-82. PubMed ID: 19708580
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal proteins and renal disease.
Kyle RA
Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
[TBL] [Abstract][Full Text] [Related]
37. [The renal pathology in light chain deposition disease].
Giannakakis KN; Faraggiana T
G Ital Nefrol; 2005; 22 Suppl 33():S53-6. PubMed ID: 16419007
[TBL] [Abstract][Full Text] [Related]
38. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.
Mehtat Ünlü Ş; Özsan H; Sarıoğlu S
Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010
[TBL] [Abstract][Full Text] [Related]
39. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions.
Herrera GA
Med Electron Microsc; 2001 Mar; 34(1):1-18. PubMed ID: 11479769
[TBL] [Abstract][Full Text] [Related]
40. Current opinions in nephrology and hypertension: kidney transplantation in patients with plasma cell dyscrasias.
Lum EL; Bunnapradist S
Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):573-580. PubMed ID: 31403474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
